Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000699
Status:
COMPLETED
Last Update Posted:
2008-08-26
First Post:
1999-11-02
Brief Title:
A Phase III Trial of Ribavirin With Escalation Isoprinosine in Asymptomatic HIV-Viremic Patients
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID